AVM
QTTB icon

Arch Venture Management’s Q32 Bio QTTB Stock Holding History

Arch Venture Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06M Hold
320,482
– – 0.3% 10
2025
Q4 		$1.06M Hold
320,482
– – 0.16% 9
2025
Q3 		$635K Hold
320,482
– – 0.13% 8
2025
Q2 		$478K Hold
320,482
– – 0.16% 9
2025
Q1 		$532K Hold
320,482
– – 0.26% 8
2024
Q4 		$1.1M Hold
320,482
– – 0.48% 7
2024
Q3 		$14.3M Hold
320,482
– – 5.49% 4
2024
Q2 		$5.75M Hold
320,482
– – 2.16% 6
2024
Q1 		$5.46M Buy
+320,482
New +$4.42M 6.8% 5

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arch Venture Management's QTTB Position: Q1 2026 in Review

Arch Venture Management held its Q32 Bio (QTTB) position steady in Q1 2026 at 320,482 shares worth $2.06M. The position accounts for 0.3% of the portfolio, ranked #10.

Arch Venture Management first reported a position in QTTB in Q1 2024 and has held it in 9 quarters since. The position peaked at $14.3M in Q3 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Arch Venture Management held 320,482 shares of Q32 Bio worth $2.06M as of Q1 2026.
  • Arch Venture Management left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up 0.3% of Arch Venture Management's portfolio in Q1 2026, its #10 holding.
  • Arch Venture Management first reported a position in Q32 Bio in Q1 2024 and has held it in 9 quarters since.
  • Arch Venture Management's Q32 Bio position peaked at $14.3M in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Arch Venture Management's 13F filing for Q1 2026, filed 15 May 2026.